These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 7598277)
1. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients. Prielipp RC; Coursin DB; Scuderi PE; Bowton DL; Ford SR; Cardenas VJ; Vender J; Howard D; Casale EJ; Murray MJ Anesth Analg; 1995 Jul; 81(1):3-12. PubMed ID: 7598277 [TBL] [Abstract][Full Text] [Related]
2. Randomised controlled trial comparing cisatracurium and vecuronium infusions in a paediatric intensive care unit. Burmester M; Mok Q Intensive Care Med; 2005 May; 31(5):686-92. PubMed ID: 15815895 [TBL] [Abstract][Full Text] [Related]
3. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia. Stevens JB; Walker SC; Fontenot JP Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594 [TBL] [Abstract][Full Text] [Related]
4. Comparison of cisatracurium and vecuronium by infusion in neonates and small infants after congenital heart surgery. Reich DL; Hollinger I; Harrington DJ; Seiden HS; Chakravorti S; Cook DR Anesthesiology; 2004 Nov; 101(5):1122-7. PubMed ID: 15505447 [TBL] [Abstract][Full Text] [Related]
5. A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients. Newman PJ; Quinn AC; Grounds RM; Hunter JM; Boyd AH; Eastwood NB; Pollard BJ; Pearson AJ; Harper NJ; Beale RJ; Sutjarittam M; Elliot JM; Bion JF Crit Care Med; 1997 Jul; 25(7):1139-42. PubMed ID: 9233738 [TBL] [Abstract][Full Text] [Related]
6. The infusion requirements and recovery characteristics of cisatracurium or atracurium in intensive care patients. Pearson AJ; Harper NJ; Pollard BJ Intensive Care Med; 1996 Jul; 22(7):694-8. PubMed ID: 8844237 [TBL] [Abstract][Full Text] [Related]
7. A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion. Mellinghoff H; Radbruch L; Diefenbach C; Buzello W Anesth Analg; 1996 Nov; 83(5):1072-5. PubMed ID: 8895288 [TBL] [Abstract][Full Text] [Related]
8. Cumulation and reversal with prolonged infusions of atracurium and vecuronium. Martineau RJ; St-Jean B; Kitts JB; Curran MC; Lindsay P; Hull KA; Miller DR Can J Anaesth; 1992 Sep; 39(7):670-6. PubMed ID: 1356646 [TBL] [Abstract][Full Text] [Related]
9. Train-of-four fade during onset of neuromuscular block with nondepolarising neuromuscular blocking agents. Gibson FM; Mirakhur RK Acta Anaesthesiol Scand; 1989 Apr; 33(3):204-6. PubMed ID: 2567104 [TBL] [Abstract][Full Text] [Related]
10. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. Rudis MI; Sikora CA; Angus E; Peterson E; Popovich J; Hyzy R; Zarowitz BJ Crit Care Med; 1997 Apr; 25(4):575-83. PubMed ID: 9142020 [TBL] [Abstract][Full Text] [Related]
11. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants. Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219 [TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats. Wastila WB; Maehr RB; Turner GL; Hill DA; Savarese JJ Anesthesiology; 1996 Jul; 85(1):169-77. PubMed ID: 8694363 [TBL] [Abstract][Full Text] [Related]
13. Sugammadex reverses neuromuscular block induced by 3-desacetyl-vecuronium, an active metabolite of vecuronium, in the anaesthetised rhesus monkey. Staals LM; van Egmond J; Driessen JJ; de Boer HD; van de Pol F; Bom AH; Booij LH Eur J Anaesthesiol; 2011 Apr; 28(4):265-72. PubMed ID: 21157358 [TBL] [Abstract][Full Text] [Related]
14. A two-center study evaluating the hemodynamic and pharmacodynamic effects of cisatracurium and vecuronium in patients undergoing coronary artery bypass surgery. Searle NR; Thomson I; Dupont C; Cannon JE; Roy M; Rosenbloom M; Gagnon L; Carrier M J Cardiothorac Vasc Anesth; 1999 Feb; 13(1):20-5. PubMed ID: 10069278 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit. Boyd AH; Eastwood NB; Parker CJ; Hunter JM Br J Anaesth; 1996 Mar; 76(3):382-8. PubMed ID: 8785138 [TBL] [Abstract][Full Text] [Related]
16. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination. Kim KS; Chun YS; Chon SU; Suh JK Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281 [TBL] [Abstract][Full Text] [Related]
17. A prospective randomized comparison of train-of-four monitoring and clinical assessment during continuous ICU cisatracurium paralysis. Baumann MH; McAlpin BW; Brown K; Patel P; Ahmad I; Stewart R; Petrini M Chest; 2004 Oct; 126(4):1267-73. PubMed ID: 15486392 [TBL] [Abstract][Full Text] [Related]
18. Continuous infusions of atracurium and vecuronium, compared with intermittent boluses of pancuronium: dose requirements and reversal. Beattie WS; Buckley DN; Forrest JB Can J Anaesth; 1992 Nov; 39(9):925-31. PubMed ID: 1360337 [TBL] [Abstract][Full Text] [Related]